<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Regeneron Awarded $450 Million to Manufacture REGN-COV2
Image Overlay - Regeneron Awarded $450 Million to Manufacture REGN-COV2

Regeneron Awarded $450 Million to Manufacture REGN-COV2

July 15, 2020

Regeneron Awarded $450 Million to Manufacture REGN-COV2

Regeneron was awarded a $450 million contract through the U.S. government-funded Operation Warp Speed to manufacture and supply REGN-COV2. The COVID-19 antibody cocktail is currently in two Phase 2/3 clinical trials. As a leader in warehouse and inventory management, Yourway can provide the full scope of all biopharmaceutical storage and distribution needs, maximizing efficiency, and decreasing risk on any candidate.

Back to Index
Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?